Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.
Awada A, Biganzoli L, Cufer T, Beex L, Lohrisch C, Batter V, Hamilton A, Nooij M, Piccart M. Awada A, et al. Among authors: lohrisch c. Eur J Cancer. 2002 Apr;38(6):773-8. doi: 10.1016/s0959-8049(01)00427-0. Eur J Cancer. 2002. PMID: 11937310 Clinical Trial.
The predictive value of HER2 in breast cancer.
Piccart M, Lohrisch C, Di Leo A, Larsimont D. Piccart M, et al. Among authors: lohrisch c. Oncology. 2001;61 Suppl 2:73-82. doi: 10.1159/000055405. Oncology. 2001. PMID: 11694791 Review.
Taxanes in the adjuvant treatment of breast cancer: why not yet?
Piccart MJ, Lohrisch C, Duchateau L, Buyse M. Piccart MJ, et al. Among authors: lohrisch c. J Natl Cancer Inst Monogr. 2001;(30):88-95. doi: 10.1093/oxfordjournals.jncimonographs.a003468. J Natl Cancer Inst Monogr. 2001. PMID: 11773299
An overview of HER2.
Lohrisch C, Piccart M. Lohrisch C, et al. Semin Oncol. 2001 Dec;28(6 Suppl 18):3-11. Semin Oncol. 2001. PMID: 11774200 Review.
Standard medical treatment for early breast cancer.
Lohrisch C, Piccart MJ. Lohrisch C, et al. Eur J Cancer. 2001 Oct;37 Suppl 7:S45-58. doi: 10.1016/s0959-8049(01)80006-x. Eur J Cancer. 2001. PMID: 11888004 Review. No abstract available.
HER2/neu as a predictive factor in breast cancer.
Lohrisch C, Piccart M. Lohrisch C, et al. Clin Breast Cancer. 2001 Jul;2(2):129-35; discussion 136-7. doi: 10.3816/CBC.2001.n.017. Clin Breast Cancer. 2001. PMID: 11899784 Review.
69 results